Cargando…
Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
INTRODUCTION: Blockage of the cerebral arteries due to thrombosis and embolism resulting in decreased blood flow to the brain, reduced oxygen supply to the brain, resulting in neuronal damage and causes astrocyte cells to secrete glial fibrillary acidic protein (GFAP). The objective of this study wa...
Autor principal: | Amalia, Lisda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722682/ https://www.ncbi.nlm.nih.gov/pubmed/35002283 http://dx.doi.org/10.2147/JIR.S342097 |
Ejemplares similares
-
Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013) -
Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023) -
Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023) -
Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022) -
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)